famotidine has been researched along with betadex in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, AR; Vavia, PR | 1 |
| Abou-Taleb, AE; Anraku, M; Hirayama, F; Iohara, D; Khaled, KA; Mady, FM; Otagiri, M; Taguchi, K; Uekama, K; Yamasaki, K | 1 |
| Abou-Taleb, AE; Hirayama, F; Iohara, D; Ishiguro, T; Khaled, KA; Mady, FM; Otagiri, M; Uekama, K; Yamasaki, K | 1 |
| Anraku, M; Hiraga, A; Hirayama, F; Iohara, D; Pipkin, JD; Uekama, K | 1 |
| Naik, JB; Patil, JS; Verma, U; Yadava, SK | 1 |
| Jamrógiewicz, M; Milewska, K | 1 |
| Goto, S; Hiroshige, R; Kasai, T; Okumura, Y; Tsunoda, C; Yokoyama, H | 1 |
7 other study(ies) available for famotidine and betadex
| Article | Year |
|---|---|
Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach.
Topics: Administration, Oral; beta-Cyclodextrins; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Compounding; Drug Stability; Famotidine; Histamine H2 Antagonists; Humans; Hypromellose Derivatives; Kinetics; Methylcellulose; Microscopy, Electron, Scanning; Perceptual Masking; Powder Diffraction; Solubility; Spectroscopy, Fourier Transform Infrared; Taste; Technology, Pharmaceutical | 2008 |
Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.
Topics: Administration, Oral; Adult; Animals; Anti-Ulcer Agents; Area Under Curve; beta-Cyclodextrins; Biological Availability; Drug Stability; Famotidine; Female; Half-Life; Humans; Intestinal Absorption; Male; Rats; Rats, Wistar; Solubility; Tablets; Taste; Young Adult | 2010 |
Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach.
Topics: beta-Cyclodextrins; Famotidine; Humans; Povidone; Solubility; Taste; Water; X-Ray Diffraction | 2010 |
Slow-release of famotidine from tablets consisting of chitosan/sulfobutyl ether β-cyclodextrin composites.
Topics: Animals; Anti-Ulcer Agents; beta-Cyclodextrins; Chitosan; Delayed-Action Preparations; Famotidine; Gels; Hydrogen-Ion Concentration; Kinetics; Male; Rats; Rats, Wistar; Solubility; Tablets | 2015 |
Screening of process variables to enhance the solubility of famotidine with 2-HydroxyPropyl-β-Cyclodextrin & PVP K-30 by using Plackett-Burman design approach.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Chemistry, Pharmaceutical; Famotidine; Solubility | 2017 |
Studies on the influence of β-cyclodextrin derivatives on the physical stability of famotidine.
Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Drug Stability; Excipients; Famotidine; Histamine H2 Antagonists; Spectroscopy, Fourier Transform Infrared; Spectroscopy, Near-Infrared | 2019 |
Optimization of the stability constants of the ternary system of diclofenac/famotidine/β-cyclodextrin by nonlinear least-squares method using theoretical equations.
Topics: beta-Cyclodextrins; Cyclodextrins; Diclofenac; Famotidine; Solubility | 2023 |